Dana Philip1, Assaf Buch1, Denish Moorthy2, Tammy M Scott2, Laurence D Parnell3, Chao-Qiang Lai3, José M Ordovás3, Jacob Selhub4, Irwin H Rosenberg2, Katherine L Tucker5, Aron M Troen6. 1. Nutrition and Brain Health Laboratory, Institute of Biochemistry, Food Science and Nutrition, Robert H Smith Faculty of Agriculture, Food and Environment, The Hebrew University of Jerusalem, Rehovot, Israel; 2. Neuroscience and Aging Laboratory. 3. Nutritional Genomics Laboratory. 4. Vitamin Metabolism Laboratory, and. 5. Nutritional Epidemiology Program, Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, MA; and Department of Clinical Laboratory and Nutritional Sciences at University of Massachusetts, Lowell, MA. 6. Nutrition and Brain Health Laboratory, Institute of Biochemistry, Food Science and Nutrition, Robert H Smith Faculty of Agriculture, Food and Environment, The Hebrew University of Jerusalem, Rehovot, Israel; Neuroscience and Aging Laboratory, aron.troen@mail.huji.ac.il.
Abstract
BACKGROUND: Folate status has been positively associated with cognitive function in many studies; however, some studies have observed associations of poor cognitive outcomes with high folate. In search of an explanation, we hypothesized that the association of folate with cognition would be modified by the interaction of high-folate status with a common 19-bp deletion polymorphism in the dihydrofolate reductase (DHFR) gene. To our knowledge, the cognitive effects of this gene have not been studied previously. OBJECTIVE: We examined the association between cognitive outcomes with the 19-bp deletion DHFR polymorphism, folate status, and their interaction with high or normal plasma folate. DESIGN: This was a pooled cross-sectional study of the following 2 Boston-based cohorts of community living adults: the Boston Puerto Rican Health Study and the Nutrition, Aging, and Memory in Elders study. Individuals were genotyped for the DHFR 19-bp deletion genotype, and plasma folate status was determined. Cognitive outcomes included the Mini-Mental State Examination, Center for Epidemiologic Studies Depression Scale, and factor scores for the domains of memory, executive function, and attention from a set of cognitive tests. RESULTS: The prevalence of the homozygous deletion (del/del) genotype was 23%. In a multivariable analysis, high folate status (>17.8 ng/mL) was associated with better memory scores than was normal-folate status (fourth-fifth quintiles compared with first-third quintiles: β ± SE = -0.22 ± 0.06, P < 0.01). Carriers of the DHFR del/del genotype had worse memory scores (β ± SE = -0.24 ± 0.10, P < 0.05) and worse executive scores (β = -0.19, P < 0.05) than did those with the del/ins and ins/ins genotypes. Finally, we observed an interaction such that carriers of the del/del genotype with high folate had significantly worse memory scores than those of both noncarriers with high-folate and del/del carriers with normal-folate (β-interaction = 0.26 ± 0.13, P < 0.05). CONCLUSIONS: This study identifies a putative gene-nutrient interaction that, if confirmed, would predict that a sizable minority carrying the del/del genotype might not benefit from high-folate status and could see a worsening of memory. An understanding of how genetic variation affects responses to high-folate exposure will help weigh risks and benefits of folate supplementation for individuals and public health.
BACKGROUND:Folate status has been positively associated with cognitive function in many studies; however, some studies have observed associations of poor cognitive outcomes with high folate. In search of an explanation, we hypothesized that the association of folate with cognition would be modified by the interaction of high-folate status with a common 19-bp deletion polymorphism in the dihydrofolate reductase (DHFR) gene. To our knowledge, the cognitive effects of this gene have not been studied previously. OBJECTIVE: We examined the association between cognitive outcomes with the 19-bp deletion DHFR polymorphism, folate status, and their interaction with high or normal plasma folate. DESIGN: This was a pooled cross-sectional study of the following 2 Boston-based cohorts of community living adults: the Boston Puerto Rican Health Study and the Nutrition, Aging, and Memory in Elders study. Individuals were genotyped for the DHFR 19-bp deletion genotype, and plasma folate status was determined. Cognitive outcomes included the Mini-Mental State Examination, Center for Epidemiologic Studies Depression Scale, and factor scores for the domains of memory, executive function, and attention from a set of cognitive tests. RESULTS: The prevalence of the homozygous deletion (del/del) genotype was 23%. In a multivariable analysis, high folate status (>17.8 ng/mL) was associated with better memory scores than was normal-folate status (fourth-fifth quintiles compared with first-third quintiles: β ± SE = -0.22 ± 0.06, P < 0.01). Carriers of the DHFR del/del genotype had worse memory scores (β ± SE = -0.24 ± 0.10, P < 0.05) and worse executive scores (β = -0.19, P < 0.05) than did those with the del/ins and ins/ins genotypes. Finally, we observed an interaction such that carriers of the del/del genotype with high folate had significantly worse memory scores than those of both noncarriers with high-folate and del/del carriers with normal-folate (β-interaction = 0.26 ± 0.13, P < 0.05). CONCLUSIONS: This study identifies a putative gene-nutrient interaction that, if confirmed, would predict that a sizable minority carrying the del/del genotype might not benefit from high-folate status and could see a worsening of memory. An understanding of how genetic variation affects responses to high-folate exposure will help weigh risks and benefits of folate supplementation for individuals and public health.
Authors: Siddharth Banka; Henk J Blom; John Walter; Majid Aziz; Jill Urquhart; Christopher M Clouthier; Gillian I Rice; Arjan P M de Brouwer; Emma Hilton; Grace Vassallo; Andrew Will; Desirée E C Smith; Yvo M Smulders; Ron A Wevers; Robert Steinfeld; Simon Heales; Yanick J Crow; Joelle N Pelletier; Simon Jones; William G Newman Journal: Am J Hum Genet Date: 2011-02-11 Impact factor: 11.025
Authors: Ivon J M van der Linden; Uyen Nguyen; Sandra G Heil; Barbara Franke; Suzanne Vloet; Henkjan Gellekink; Martin den Heijer; Henk J Blom Journal: Mol Genet Metab Date: 2007-03-02 Impact factor: 4.797
Authors: Paul S Aisen; Lon S Schneider; Mary Sano; Ramon Diaz-Arrastia; Christopher H van Dyck; Myron F Weiner; Teodoro Bottiglieri; Shelia Jin; Karen T Stokes; Ronald G Thomas; Leon J Thal Journal: JAMA Date: 2008-10-15 Impact factor: 56.272
Authors: Christopher B Brady; J Michael Gaziano; Roberta A Cxypoliski; Peter D Guarino; James S Kaufman; Stuart R Warren; Pamela Hartigan; David S Goldfarb; Rex L Jamison Journal: Am J Kidney Dis Date: 2009-07-23 Impact factor: 8.860
Authors: Anna Stanisławska-Sachadyn; Karen S Brown; Laura E Mitchell; Jayne V Woodside; Ian S Young; John M Scott; Liam Murray; Colin A Boreham; Helene McNulty; J J Strain; Alexander S Whitehead Journal: Hum Genet Date: 2008-02-05 Impact factor: 4.132
Authors: Robert Clarke; Derrick Bennett; Sarah Parish; Sarah Lewington; Murray Skeaff; Simone J P M Eussen; Catharina Lewerin; David J Stott; Jane Armitage; Graeme J Hankey; Eva Lonn; J David Spence; Pilar Galan; Lisette C de Groot; Jim Halsey; Alan D Dangour; Rory Collins; Francine Grodstein Journal: Am J Clin Nutr Date: 2014-06-25 Impact factor: 7.045
Authors: Emily C McGowan; Xiumei Hong; Jacob Selhub; Ligi Paul; Robert A Wood; Elizabeth C Matsui; Corinne A Keet; Xiaobin Wang Journal: J Allergy Clin Immunol Pract Date: 2019-06-25
Authors: Stella A Belonwu; Yaqiao Li; Daniel G Bunis; Arjun Arkal Rao; Caroline Warly Solsberg; Tomiko Oskotsky; Alice L Taubes; Brian Grone; Kelly A Zalocusky; Gabriela K Fragiadakis; Yadong Huang; Marina Sirota Journal: Front Aging Neurosci Date: 2022-04-27 Impact factor: 5.702
Authors: Brenda Perez-Aguirre; Uriel Soto-Barreras; Juan Pablo Loyola-Rodriguez; Juan Francisco Reyes-Macias; Miguel Angel Santos-Diaz; Alejandra Loyola-Leyva; Obed Garcia-Cortes Journal: Korean J Pediatr Date: 2018-09-15